Does ELTROMBOPAG Cause Aplastic anaemia? 131 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 131 reports of Aplastic anaemia have been filed in association with ELTROMBOPAG. This represents 2.4% of all adverse event reports for ELTROMBOPAG.
131
Reports of Aplastic anaemia with ELTROMBOPAG
2.4%
of all ELTROMBOPAG reports
56
Deaths
45
Hospitalizations
How Dangerous Is Aplastic anaemia From ELTROMBOPAG?
Of the 131 reports, 56 (42.7%) resulted in death, 45 (34.4%) required hospitalization, and 10 (7.6%) were considered life-threatening.
Is Aplastic anaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELTROMBOPAG. However, 131 reports have been filed with the FAERS database.
What Other Side Effects Does ELTROMBOPAG Cause?
Platelet count decreased (968)
Death (629)
Drug ineffective (554)
Product use in unapproved indication (303)
Thrombocytopenia (262)
Off label use (255)
Headache (229)
Pyrexia (229)
Haemoglobin decreased (213)
Pneumonia (204)
What Other Drugs Cause Aplastic anaemia?
ECULIZUMAB (345)
CYCLOPHOSPHAMIDE (332)
CYCLOSPORINE (331)
METHOTREXATE (281)
BUSULFAN (220)
FLUDARABINE (220)
ETOPOSIDE (186)
VINCRISTINE (173)
CYTARABINE (163)
ELTROMBOPAG OLAMINE (149)
Which ELTROMBOPAG Alternatives Have Lower Aplastic anaemia Risk?
ELTROMBOPAG vs ELTROMBOPAG OLAMINE
ELTROMBOPAG vs ELUXADOLINE
ELTROMBOPAG vs ELVITEGRAVIR
ELTROMBOPAG vs EMAPALUMAB
ELTROMBOPAG vs EMAPALUMAB-LZSG